In-Bore MR-Guided Biopsy Systems and Utility of PI-RADS
SourceTopics in Magnetic Resonance Imaging, 25, 3, (2016), pp. 119-123
Article / Letter to editor
Display more detailsDisplay less details
Topics in Magnetic Resonance Imaging
SubjectRadboudumc 15: Urological cancers RIHS: Radboud Institute for Health Sciences
A diagnostic dilemma exists in cases wherein a patient with clinical suspicion for prostate cancer has a negative transrectal ultrasound-guided biopsy session. Although transrectal ultrasound-guided biopsy is the standard of care, a paradigm shift is being observed. In biopsy-naive patients and patients with at least 1 negative biopsy session, multiparametric magnetic resonance imaging (MRI) is being utilized for tumor detection and subsequent targeting. Several commercial devices are now available for targeted prostate biopsy ranging from transrectal ultrasound-MR fusion biopsy to in bore MR-guided biopsy. In this review, we will give an update on the current status of in-bore MRI-guided biopsy systems and discuss value of prostate imaging-reporting and data system (PIRADS).
Upload full text